Literature DB >> 16507914

Identification of differential protein expression associated with development of unstable human carotid plaques.

Mark Slevin1, Abdul Baset Elasbali, Marta Miguel Turu, Jerzy Krupinski, Lina Badimon, John Gaffney.   

Abstract

Rupture-prone unstable arterial plaques develop concomitantly with the appearance of intraplaque hemorrhage and tissue ulceration, in association with deregulation of smooth muscle cell mitogenesis and leakage of newly formed blood vessels. Using microarray technology, we have identified novel protein deregulation associated with unstable carotid plaque regions. Overexpression of proapoptotic proteins caspase-9 and TRAF4 was seen in endothelial cells and smooth muscle cells from unstable hemorrhagic and ulcerated plaque regions. Topoisomerase-II-alpha (TOPO-II-alpha), which is associated with DNA repair mechanisms, was also overexpressed by these cells. Cell signaling molecules c-src, G-protein-coupled receptor kinase-interacting protein (GIT1), and c-jun N-terminal kinase (JNK) were up-regulated in endothelial cells from the same areas, whereas an increase in expression of junctional adhesion molecule-1 (JAM-1) in blood vessels and infiltrating macrophages from inflammatory regions might form part of a leukocyte rolling response, increasing the plaque volume. Grb2-like adaptor protein (Gads), responsible for differentiation of monocytes into macrophages, was expressed by macrophages from unstable plaques, suggesting a potential mechanism through which increased scavenging could occur in rupture-prone areas. We conclude that modulation of novel cell signaling intermediates, such as those described here, could be useful in the therapy of angiogenesis and apoptosis, designed to reduce unstable plaque formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507914      PMCID: PMC1606543          DOI: 10.2353/ajpath.2006.050471

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Differential gene expression in primary and recurrent carotid stenosis.

Authors:  Kenneth J Woodside; Ambrosio Hernandez; Farin W Smith; Xiang Ying Xue; Mingdao Hu; John A Daller; Glenn C Hunter
Journal:  Biochem Biophys Res Commun       Date:  2003-03-14       Impact factor: 3.575

2.  S1P induces FA remodeling in human pulmonary endothelial cells: role of Rac, GIT1, FAK, and paxillin.

Authors:  Yasushi Shikata; Konstantin G Birukov; Joe G N Garcia
Journal:  J Appl Physiol (1985)       Date:  2002-12-13

Review 3.  The role of MAP kinases in endothelial activation.

Authors:  Ryan J Hoefen; Bradford C Berk
Journal:  Vascul Pharmacol       Date:  2002-05       Impact factor: 5.773

4.  Gene expression profiling of apoptosis-related genes in human atherosclerosis: upregulation of death-associated protein kinase.

Authors:  Wim Martinet; Dorien M Schrijvers; Guido R Y De Meyer; Jeff Thielemans; Michiel W M Knaapen; Arnold G Herman; Mark M Kockx
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-12-01       Impact factor: 8.311

5.  C-reactive protein and rapidly progressive coronary artery disease--is there any relation?

Authors:  Michael N Zairis; Stavros J Manousakis; Alexander S Stefanidis; Denis P Vitalis; Evangelos M Tsanis; Seraphim M Hadjigeorgiou; Constantine N Fakiolas; Evangelos G Pissimissis; Christopher D Olympios; Stefanos G Foussas
Journal:  Clin Cardiol       Date:  2003-02       Impact factor: 2.882

6.  Induced expression and association of the Mona/Gads adapter and Gab3 scaffolding protein during monocyte/macrophage differentiation.

Authors:  Caroline Bourgin; Roland P Bourette; Sylvie Arnaud; Yan Liu; Larry R Rohrschneider; Guy Mouchiroud
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

7.  Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis.

Authors:  Romeo Ricci; Grzegorz Sumara; Izabela Sumara; Izabela Rozenberg; Michael Kurrer; Alexander Akhmedov; Martin Hersberger; Urs Eriksson; Franz R Eberli; Burkhard Becher; Jan Borén; Mian Chen; Myron I Cybulsky; Kathryn J Moore; Mason W Freeman; Erwin F Wagner; Christian M Matter; Thomas F Lüscher
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

8.  Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase.

Authors:  You Cheng Xu; Ru Feng Wu; Ying Gu; Yih-Sheng Yang; Meng-Chun Yang; Fiemu E Nwariaku; Lance S Terada
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

9.  Structural basis for SH3 domain-mediated high-affinity binding between Mona/Gads and SLP-76.

Authors:  Maria Harkiolaki; Marc Lewitzky; Robert J C Gilbert; E Yvonne Jones; Roland P Bourette; Guy Mouchiroud; Holger Sondermann; Ismail Moarefi; Stephan M Feller
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 10.  Apoptosis induced by topoisomerase inhibitors.

Authors:  Olivier Sordet; Qasim A Khan; Kurt W Kohn; Yves Pommier
Journal:  Curr Med Chem Anticancer Agents       Date:  2003-07
View more
  14 in total

1.  JNK and NF-κB signaling pathways are involved in cytokine changes in patients with congenital heart disease prior to and after transcatheter closure.

Authors:  Shunyang Fan; Kefang Li; Deyin Zhang; Fuyun Liu
Journal:  Exp Ther Med       Date:  2017-12-05       Impact factor: 2.447

2.  GPCR kinase 2 interacting protein 1 (GIT1) regulates osteoclast function and bone mass.

Authors:  Prashanthi Menon; Guoyong Yin; Elaine M Smolock; Michael J Zuscik; Chen Yan; Bradford C Berk
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

3.  Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease.

Authors:  Lina Badimon; Teresa Padró; Gemma Vilahur
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-04

4.  Early epigenetic changes of Alzheimer's disease in the human hippocampus.

Authors:  Idoia Blanco-Luquin; Blanca Acha; Amaya Urdánoz-Casado; Javier Sánchez-Ruiz De Gordoa; Janire Vicuña-Urriza; Miren Roldán; Alberto Labarga; María Victoria Zelaya; Carolina Cabello; Iván Méndez-López; Maite Mendioroz
Journal:  Epigenetics       Date:  2020-04-07       Impact factor: 4.528

5.  BRCA2 variants and cardiovascular disease in a multi-ethnic study.

Authors:  Kevin Zbuk; Changchun Xie; Robin Young; Mahyar Heydarpour; Guillaume Pare; A Darlene Davis; Ruby Miller; Matthew B Lanktree; Danish Saleheen; John Danesh; Salim Yusuf; James C Engert; Robert A Hegele; Sonia S Anand
Journal:  BMC Med Genet       Date:  2012-07-18       Impact factor: 2.103

6.  Gene expression differences between stroke-associated and asymptomatic carotid plaques.

Authors:  Jani Saksi; Petra Ijäs; Krista Nuotio; Riitta Sonninen; Lauri Soinne; Oili Salonen; Eija Saimanen; Jarno Tuimala; Erno M Lehtonen-Smeds; Markku Kaste; Petri T Kovanen; Perttu J Lindsberg
Journal:  J Mol Med (Berl)       Date:  2011-05-24       Impact factor: 4.599

7.  Transcription and translation of human F11R gene are required for an initial step of atherogenesis induced by inflammatory cytokines.

Authors:  Bani M Azari; Jonathan D Marmur; Moro O Salifu; Yigal H Ehrlich; Elizabeth Kornecki; Anna Babinska
Journal:  J Transl Med       Date:  2011-06-26       Impact factor: 5.531

8.  Proteomic Biomarkers of Atherosclerosis.

Authors:  F Vivanco; L R Padial; V M Darde; F de la Cuesta; G Alvarez-Llamas; Natacha Diaz-Prieto; M G Barderas
Journal:  Biomark Insights       Date:  2008-03-12

9.  C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression.

Authors:  Marta M Turu; Mark Slevin; Sabine Matou; David West; Cristina Rodríguez; Ana Luque; Marta Grau-Olivares; Lina Badimon; Jose Martinez-Gonzalez; Jerzy Krupinski
Journal:  BMC Cell Biol       Date:  2008-09-02       Impact factor: 4.241

10.  Secreted proteins from carotid endarterectomy: an untargeted approach to disclose molecular clues of plaque progression.

Authors:  Silvia Rocchiccioli; Gualtiero Pelosi; Silvia Rosini; Michele Marconi; Federica Viglione; Lorenzo Citti; Mauro Ferrari; Maria Giovanna Trivella; Antonella Cecchettini
Journal:  J Transl Med       Date:  2013-10-16       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.